Vergoeding 2017-2021 voor ATC-subgroep N06AB : Selectieve serotonine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| N06AB03 Fluoxetine (Prozac ®) | 782.850 | 818.890 | 1.000.500 | 1.559.900 | 1.232.400 |
| N06AB04 Citalopram (Cipramil ®) | 3.411.000 | 3.534.600 | 3.867.100 | 3.883.700 | 3.398.300 |
| N06AB05 Paroxetine (Seroxat ®) | 4.167.500 | 3.712.400 | 3.861.500 | 4.227.800 | 4.320.500 |
| N06AB06 Sertraline (Zoloft ®) | 2.022.100 | 1.996.300 | 2.030.100 | 2.085.700 | 2.109.200 |
| N06AB08 Fluvoxamine (Fevarin ®) | 762.810 | 752.020 | 754.990 | 761.890 | 818.630 |
| N06AB10 Escitalopram (Lexapro ®) | 1.320.400 | 1.461.000 | 1.702.300 | 2.038.700 | 2.089.400 |
| Totaal | 12.466.660 | 12.275.210 | 13.216.490 | 14.557.690 | 13.968.430 |